Changing Antimicrobial Susceptibility Epidemiology of Helicobacter pylori Strains in Japan between 2002 and 2005
Open Access
- 1 December 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 45 (12), 4006-4010
- https://doi.org/10.1128/jcm.00740-07
Abstract
Surveillance of Helicobacter pylori antimicrobial susceptibility reflecting the general population in Japan is limited. The antimicrobial susceptibilities of 3,707 H. pylori strains isolated from gastric mucosa samples of previously untreated patients diagnosed with gastroduodenal diseases at 36 medical facilities located throughout Japan between October 2002 and September 2005 were evaluated. Using an agar dilution method for antimicrobial susceptibility testing of H. pylori, the MIC distributions and trends during the study period for clarithromycin, amoxicillin, and metronidazole were studied. While the MIC50 and MIC90 for clarithromycin did not change during the 3-year period, the MIC80 showed a 128-fold increase. Furthermore, the rate of resistance increased yearly from 18.9% (2002 to 2003) to 21.1% (2003 to 2004) and 27.7% (2004 to 2005). With a resistance rate of 19.2% among males compared to 27.0% among females, a significant gender difference was observed (P < 0.0001). Our study shows that in Japan, there is an evolving trend towards increased resistance to clarithromycin with geographical and gender differences as well as between clinical disease conditions. No significant changes in resistance were observed for amoxicillin and metronidazole during the period. While the benefit of H. pylori antimicrobial susceptibility testing has been debated in Japan, current empirical regimens are not based on susceptibility data representative of the general population. The development of an effective H. pylori eradication regimen in Japan will require continued resistance surveillance as well as a better understanding of the epidemiology of resistance.Keywords
This publication has 23 references indexed in Scilit:
- [H. pylori eradication package set (Lansap)].2005
- Effectiveness of AntiinfectivesChemotherapy, 2005
- Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected AdultsAntimicrobial Agents and Chemotherapy, 2005
- Antimicrobial Resistance Incidence and Risk Factors amongHelicobacter pylori–Infected Persons, United StatesEmerging Infectious Diseases, 2004
- Helicobacter pyloriInfectionNew England Journal of Medicine, 2002
- Prevalence of resistant Helicobacter pylori isolates in Bulgarian childrenJournal of Medical Microbiology, 2002
- Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre studyDigestive and Liver Disease, 2000
- Stable amoxicillin resistance in Helicobacter pyloriThe Lancet, 1998
- Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcerAlimentary Pharmacology & Therapeutics, 1997
- Cure of duodenal ulcer associated with eradication of Helicobacter pyloriThe Lancet, 1990